Results 111 to 120 of about 7,055,245 (153)

Drug-Induced Liver Injury Associated With the Angiotensin II Receptor Blocker Losartan in a 59-Year-Old Woman With Hypertension: A Case Report. [PDF]

Am J Case Rep
Al-Ajaj A, Melki W.
europepmc   +1 more source

Repurposing the angiotensin II receptor blocker valsartan to inhibit penicillin-binding protein 3 and its mutants in <i>Haemophilus influenzae</i>: a comprehensive <i>in silico</i> approach. [PDF]

Front Bioinform
Kacha S, Arun J, Nargund N, Joshi T, Mathpal S, Ramaiah S, Anbarasu A.   +6 more
europepmc   +1 more source

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine. [PDF]

Cureus
Hiremath J, Kirpalani A, Chafekar D, Jayagopal PB, Ray S, Chopra VK, Dani S, Tripathi K, Sawhney JPS, Oomman A, Sathe S, Abdullakutty J, Kher V, Dewan D, Sharma K, Shete M, Vali PS, Jain S, Swami OC.   +18 more
europepmc   +1 more source

Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients. [PDF]

Eur Heart J Cardiovasc Pharmacother, 2020
Acanfora D, Ciccone MM, Scicchitano P, Acanfora C, Casucci G.   +4 more
europepmc   +1 more source

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. [PDF]

Infect Control Hosp Epidemiol, 2021
Javanmard SH, Heshmat-Ghahdarijani K, Vaseghi G.   +2 more
europepmc   +1 more source

Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair. [PDF]

JSES Int
Fong S, Pettinelli NJ, Lee MS, Macleod JS, Gillinov SM, Monahan PF, Moran J, Jonnalagadda A, Mahatme RJ, Apostolakos JM, Jimenez AE.   +10 more
europepmc   +1 more source

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. [PDF]

Int J Mol Sci, 2020
Fujinaga Y, Kawaratani H, Kaya D, Tsuji Y, Ozutsumi T, Furukawa M, Kitagawa K, Sato S, Nishimura N, Sawada Y, Takaya H, Kaji K, Shimozato N, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H.   +17 more
europepmc   +1 more source

Potential Hepatoprotective Effects of Irbesartan, an Accessible Angiotensin II Receptor Blocker, Against Cisplatin-Induced Liver Injury in a Rat Model. [PDF]

Turk J Pharm Sci
Ertunç O, Erzurumlu Y, Savran M, Çataklı D, Doğan Kıran E, Pekgöz Ş.   +5 more
europepmc   +1 more source

A Five-Year Prospective, Randomized, Open-Label Study of Standard-Dose Versus Low-Dose Prolonged-Release Tacrolimus With or Without Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. [PDF]

Clin Transplant
Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Prasad GVR, Senécal L, Wolff JL, Schwartz JJ, Rush DN.   +12 more
europepmc   +1 more source

Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan. [PDF]

Circ Heart Fail, 2019
Clements RT, Vang A, Fernandez-Nicolas A, Kue NR, Mancini TJ, Morrison AR, Mallem K, McCullough DJ, Choudhary G.   +8 more
europepmc   +1 more source